BAY 3018250
/ Bayer
- LARVOL DELTA
Home
Next
Prev
1 to 8
Of
8
Go to page
1
February 12, 2025
A Study to Learn How Safe BAY3018250 is, How it Moves Into, Through and Out of the Body, and How it Affects the Body in Healthy Chinese Participants
(clinicaltrials.gov)
- P1 | N=24 | Completed | Sponsor: Bayer | Active, not recruiting ➔ Completed
Trial completion • Cardiovascular
February 06, 2025
A Study to Learn About How Safe BAY3018250 is and What Happens to it in Healthy Japanese Men and Adult Participants Aged 18 to 55 Years
(clinicaltrials.gov)
- P1 | N=39 | Completed | Sponsor: Bayer | Recruiting ➔ Completed
Trial completion • Cardiovascular
November 26, 2024
A Study to Learn How Safe BAY3018250 is, How it Moves Into, Through and Out of the Body, and How it Affects the Body in Healthy Chinese Participants
(clinicaltrials.gov)
- P1 | N=24 | Active, not recruiting | Sponsor: Bayer | Not yet recruiting ➔ Active, not recruiting
Enrollment closed • Cardiovascular
October 01, 2024
A Study to Learn How Safe BAY3018250 Is, How It Moves Into, Through and Out of the Body, and How It Affects the Body in Healthy Chinese Participants
(clinicaltrials.gov)
- P1 | N=24 | Not yet recruiting | Sponsor: Bayer
New P1 trial • Cardiovascular
October 01, 2024
A Study to Learn About How Safe BAY3018250 is and What Happens to it in Healthy Japanese Men and Adult Participants Aged 18 to 55 Years
(clinicaltrials.gov)
- P1 | N=39 | Recruiting | Sponsor: Bayer | Not yet recruiting ➔ Recruiting
Enrollment open • Cardiovascular
August 20, 2024
A Study to Learn About How Safe BAY3018250 is and What Happens to it in Healthy Japanese Men and Adult Participants Aged 18 to 55 Years
(clinicaltrials.gov)
- P1 | N=39 | Not yet recruiting | Sponsor: Bayer
New P1 trial • Cardiovascular
June 21, 2024
SIRIUS: A Study to Learn More About How Well BAY3018250 Works and How Safe it is for People With Proximal Deep Vein Thrombosis
(clinicaltrials.gov)
- P2 | N=255 | Recruiting | Sponsor: Bayer | Trial completion date: Jul 2025 ➔ Oct 2025 | Trial primary completion date: May 2025 ➔ Aug 2025
Trial completion date • Trial primary completion date • Cardiovascular • Hematological Disorders • Thrombosis • Venous Thromboembolism
February 28, 2024
SIRIUS: A Study to Learn More About How Well BAY3018250 Works and How Safe it is for People With Proximal Deep Vein Thrombosis
(clinicaltrials.gov)
- P2 | N=255 | Recruiting | Sponsor: Bayer | Not yet recruiting ➔ Recruiting
Enrollment open • Cardiovascular • Hematological Disorders • Thrombosis • Venous Thromboembolism
1 to 8
Of
8
Go to page
1